Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition

Abstract : Reduction in nucleotide pools through the inhibition of mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) has been demonstrated to effectively reduce cancer cell proliferation and tumour growth. The current study sought to investigate whether this antiproliferative effect could be enhanced by combining Chk1 kinase inhibition. The pharmacological activity of DHODH inhibitor teriflunomide was more selective towards transformed mouse embryonic fibroblasts than their primary or immortalised counterparts, and this effect was amplified when cells were subsequently exposed to PF477736 Chk1 inhibitor. Flow cytometry analyses revealed substantial accumulations of cells in S and G2/M phases, followed by increased cytotoxicity which was characterised by caspase 3-dependent induction of cell death. Associating PF477736 with teriflunomide also significantly sensitised SUM159 and HCC1937 human triple negative breast cancer cell lines to dihydroorotate dehydrogenase inhibition. The main characteristic of this effect was the sustained accumulation of teriflunomide-induced DNA damage as cells displayed increased phospho serine 139 H2AX (γH2AX) levels and concentration-dependent phosphorylation of Chk1 on serine 345 upon exposure to the combination as compared with either inhibitor alone. Importantly a similar significant increase in cell death was observed upon dual siRNA mediated depletion of Chk1 and DHODH in both murine and human cancer cell models. Altogether these results suggest that combining DHODH and Chk1 inhibitions may be a strategy worth considering as a potential alternative to conventional chemotherapies.
Type de document :
Article dans une revue
Liste complète des métadonnées

Littérature citée [49 références]  Voir  Masquer  Télécharger
Contributeur : Nathalie Salvy-Cordoba <>
Soumis le : mercredi 11 mars 2020 - 14:14:22
Dernière modification le : vendredi 27 mars 2020 - 02:22:34
Archivage à long terme le : : vendredi 12 juin 2020 - 15:46:15


Fichiers éditeurs autorisés sur une archive ouverte


Distributed under a Creative Commons Paternité 4.0 International License



Stéphanie Arnould, Genevieve Rodier, Gisèle Matar, Charles Vincent, Nelly Pirot, et al.. Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition. Oncotarget, Impact journals, 2017, 8 (56), pp.95206 - 95222. ⟨10.18632/oncotarget.19199⟩. ⟨hal-02291385⟩



Consultations de la notice


Téléchargements de fichiers